Menu
Book A call

Maps
Partnership

Leveraging the MAPS protocol, this unique experiential training opportunity allows practitioners to deepen their understanding of MDMA-Assisted Therapy.

PSYCHEDELIC EXPERIENTIAL OPPORTUNITIES FOR MDMA-ASSISTED THERAPY

Numinus has submitted a Clinical Trial Application (CTA) to Health Canada to enable MDMA-Assisted Therapy Experiential Opportunities for practitioners as part of an investigational Phase 1 clinical trial.

If the CTA is approved, MAPS will provide Numinus with permission to use its protocol as part of this Experiential Opportunity, the first such permission granted by MAPS.

HOW YOU CAN
GET INVOLVED

Practitioners who complete our MDMA-Assisted Therapy education program, or have already completed previous MDMA-Assisted Therapy training and are qualified to enrol in our Practical Applications course, would be able to apply to participate in the experiential clinical trial - enabling them to observe, deliver, and receive the therapeutic protocol as part of their training experience. Sign up for our mailing list below to be notified when applications open.

BE THE FIRST TO KNOW

Stay up to date on MDMA-Assisted Therapy
opportunities and our partnership with MAPS.
Numiverse Signup Form
By signing up you consent to the Privacy Policy & Terms of Use.
Questions?
Call us toll-free 1-833-NUMINUS (686-4687)
crosschevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram